1. Home
  2. IMAB vs LSBK Comparison

IMAB vs LSBK Comparison

Compare IMAB & LSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • LSBK
  • Stock Information
  • Founded
  • IMAB 2014
  • LSBK 1891
  • Country
  • IMAB United States
  • LSBK United States
  • Employees
  • IMAB N/A
  • LSBK N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • LSBK Savings Institutions
  • Sector
  • IMAB Health Care
  • LSBK Finance
  • Exchange
  • IMAB Nasdaq
  • LSBK Nasdaq
  • Market Cap
  • IMAB 79.9M
  • LSBK 91.1M
  • IPO Year
  • IMAB 2020
  • LSBK 2006
  • Fundamental
  • Price
  • IMAB $0.95
  • LSBK $16.18
  • Analyst Decision
  • IMAB Strong Buy
  • LSBK
  • Analyst Count
  • IMAB 3
  • LSBK 0
  • Target Price
  • IMAB $8.00
  • LSBK N/A
  • AVG Volume (30 Days)
  • IMAB 289.3K
  • LSBK 3.4K
  • Earning Date
  • IMAB 03-13-2025
  • LSBK 01-24-2025
  • Dividend Yield
  • IMAB N/A
  • LSBK 3.38%
  • EPS Growth
  • IMAB N/A
  • LSBK 7.32
  • EPS
  • IMAB N/A
  • LSBK 0.88
  • Revenue
  • IMAB $3,313,984.00
  • LSBK $25,846,000.00
  • Revenue This Year
  • IMAB N/A
  • LSBK N/A
  • Revenue Next Year
  • IMAB N/A
  • LSBK N/A
  • P/E Ratio
  • IMAB N/A
  • LSBK $17.98
  • Revenue Growth
  • IMAB N/A
  • LSBK N/A
  • 52 Week Low
  • IMAB $0.84
  • LSBK $10.30
  • 52 Week High
  • IMAB $2.00
  • LSBK $16.56
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 43.17
  • LSBK 71.76
  • Support Level
  • IMAB $0.95
  • LSBK $15.45
  • Resistance Level
  • IMAB $1.04
  • LSBK $15.78
  • Average True Range (ATR)
  • IMAB 0.06
  • LSBK 0.40
  • MACD
  • IMAB -0.01
  • LSBK 0.12
  • Stochastic Oscillator
  • IMAB 10.53
  • LSBK 87.81

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About LSBK Lake Shore Bancorp Inc.

Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and, to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.

Share on Social Networks: